Press release
The acidity of tumours impairs the effectiveness of anti-cancer therapies, according to a University of Dundee study that could lead to a new generation of immunotherapy treatments
Press release
The acidity of tumours impairs the effectiveness of anti-cancer therapies, according to a University of Dundee study that could lead to a new generation of immunotherapy treatments
Press release
Students will have the opportunity to earn two degrees as a major new partnership is launched between the University of Dundee and the Indonesia International Institute for Life Sciences (i3L)
Press release
A successful collaboration between the University of Dundee and pharmaceutical company Eisai Co Ltd aiming to create innovative new cancer drugs has been extended for a further three years.
Press release
An international collaboration, featuring scientists from the University of Dundee, has made a breakthrough they hope will help futureproof a revolutionary new field of drug discovery by preventing resistance in cancer therapy.
Press release
Scientists have designed a novel molecule capable of destroying an as-yet undruggable cancer-causing protein – and are making it available for researchers around the world to use in their own work, free of charge
Press release
University of Dundee researcher Professor Doreen Cantrell has been appointed as a trustee of one of the world’s biggest cancer charities.
Press release
University of Dundee spinout Amphista Therapeutics has been designated as one of the world’s most promising biotechnology companies.
Press release
The University of Dundee has received an award of funding to develop a new therapeutic approach for inflammatory disorders, including inflammatory bowel disease (IBD)
Press release
University of Dundee spinout Amphista Therapeutics will work with global biopharmaceutical companies as part of strategic collaborations potentially worth more than $2 billion.
Press release
University of Dundee research to tackle some of the world’s deadliest diseases has been boosted by new funding from the Bill & Melinda Gates Foundation.